174 related articles for article (PubMed ID: 11422147)
1. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells.
Virchow JC; Faehndrich S; Nassenstein C; Bock S; Matthys H; Luttmann W
Clin Exp Allergy; 2001 Jun; 31(6):836-44. PubMed ID: 11422147
[TBL] [Abstract][Full Text] [Related]
2. Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitro.
Becler K; Håkansson L; Rak S
Allergy; 2002 Nov; 57(11):1021-8. PubMed ID: 12358998
[TBL] [Abstract][Full Text] [Related]
3. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
4. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
5. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
[TBL] [Abstract][Full Text] [Related]
6. Does leukotriene modulation of eosinophil function explain the therapeutic effectiveness of receptor antagonists in some patients with asthma?
Busse WW
Clin Exp Allergy; 2001 Jun; 31(6):806-7. PubMed ID: 11422142
[No Abstract] [Full Text] [Related]
7. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
8. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
9. [Study on the effect of cysteinyl leukotriene antagonist, pranlukast hydrate, on adhesive interaction between eosinophils and pulmonary endothelial cells].
Nogimura M; Nagata M; Sutani A; Saito K; Sakamoto Y
Nihon Kokyuki Gakkai Zasshi; 2002 Dec; 40(12):919-24. PubMed ID: 12692940
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
Casale TB; Erger RA; Little MM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
[TBL] [Abstract][Full Text] [Related]
11. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
[TBL] [Abstract][Full Text] [Related]
12. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
14. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals.
Lee E; Robertson T; Smith J; Kilfeather S
Am J Respir Crit Care Med; 2000 Jun; 161(6):1881-6. PubMed ID: 10852761
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration.
Erger RA; Casale TB
Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492
[TBL] [Abstract][Full Text] [Related]
17. The effect of transendothelial migration on eosinophil function.
Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation.
Kushiya M; Saito K; Kikuchi I; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2006; 140 Suppl 1():17-22. PubMed ID: 16772722
[TBL] [Abstract][Full Text] [Related]
19. Role of vascular cell adhesion molecule-1 and platelet-activating factor in selective eosinophil migration across vascular endothelial cells.
Sano H; Nakagawa N; Nakajima H; Yoshida S; Iwamoto I
Int Arch Allergy Immunol; 1995 Aug; 107(4):533-40. PubMed ID: 7542515
[TBL] [Abstract][Full Text] [Related]
20. Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis.
Saito H; Morikawa H; Howie K; Crawford L; Baatjes AJ; Denburg E; Cyr MM; Denburg JA
Immunology; 2004 Oct; 113(2):246-52. PubMed ID: 15379985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
